disrupt 发表于 2025-3-25 05:37:33

http://reply.papertrans.cn/2/113/11221/11221-21.png

Pde5-Inhibitors 发表于 2025-3-25 07:39:06

Submitted on: 09 May 2018.
Revised on: 02 July 2018.
Accepted on: 07 August 2018.

___________________Hepatic Oncology---FUTURE MEDICINE LTD

profligate 发表于 2025-3-25 14:41:52

Submitted on: 10 December 2023.
Revised on: 05 February 2024.
Accepted on: 03 March 2024.

___________________Hepatic Oncology---FUTURE MEDICINE LTD

干涉 发表于 2025-3-25 16:27:31

Submitted on: 24 January 2018.
Revised on: 14 March 2018.
Accepted on: 11 May 2018.

___________________Hepatic Oncology---FUTURE MEDICINE LTD

规范要多 发表于 2025-3-25 20:43:58

http://reply.papertrans.cn/2/113/11221/11221-25.png

旅行路线 发表于 2025-3-26 03:28:41

Submitted on: 15 October 2000.
Revised on: 10 January 2001.
Accepted on: 11 February 2001.

___________________Hepatic Oncology---FUTURE MEDICINE LTD

Innocence 发表于 2025-3-26 05:45:15

http://reply.papertrans.cn/2/113/11221/11221-27.png

窗帘等 发表于 2025-3-26 09:24:51

http://reply.papertrans.cn/2/113/11221/11221-28.png

无底 发表于 2025-3-26 14:46:17

http://reply.papertrans.cn/2/113/11221/11221-29.png

profligate 发表于 2025-3-26 19:11:17

http://reply.papertrans.cn/2/113/11221/11221-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊Hepatic Oncology 2024/2025影响因子:1.241 (HEPAT ONCOL) (2045-0923). (ONCOLOGY)(肿瘤学)Emerging Sources Citation Index